| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/26/2011 | US7931022 Method and apparatus for dispensing inhalator medicament |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2462657C Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2377529C Injectable hyaluronate-sulfated polysaccharide conjugates |
| 04/26/2011 | CA2364948C C16 unsaturated fp-selective prostaglandins analogs |
| 04/26/2011 | CA2337988C Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/21/2011 | WO2011047345A2 Methods of treating diseases of conditions using mesenchymal stem cells |
| 04/21/2011 | WO2011047277A2 Release of agents from cells |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047173A2 Pharmaceutical compositions for oral administration |
| 04/21/2011 | WO2011047093A2 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | WO2011046964A2 Inhibitors of bruton's tyrosine kinase |
| 04/21/2011 | WO2011046599A2 Treatment and prognosis with thalidomide in multiple myeloma based on karyotyping and gene expression profiling |
| 04/21/2011 | WO2011045668A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010141824A3 Use of targeted nitroxide agents in bone healing |
| 04/21/2011 | WO2010124283A4 Methods and compositions relating to hematologic malignancies |
| 04/21/2011 | WO2010120817A3 Nanochanneled device and related methods |
| 04/21/2011 | WO2010111525A9 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum |
| 04/21/2011 | WO2010002835A3 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 04/21/2011 | US20110093020 Poly-porous hollow screw for target delivery of growth factors and stem cells:the design and potential clinical application |
| 04/21/2011 | US20110092953 Flowable Carrier Matrix |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092589 Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
| 04/21/2011 | US20110092575 Sirna of human osteopontin |
| 04/21/2011 | US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 04/21/2011 | US20110092561 Benzoisoindole derivatives for the treatment of pain |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092528 Piperidinyl compounds that selectively bind integrins |
| 04/21/2011 | US20110092519 5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092497 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 04/21/2011 | US20110092468 Pharmaceutical Calcimimetics |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092426 Oral calcitonin compositions and applications thereof |
| 04/21/2011 | US20110092425 Method of drug delivery for bone anabolic protein |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091583 Antiallergic marine biopolymers |
| 04/21/2011 | US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells |
| 04/21/2011 | US20110091554 Injectable composite material suitable for use as a bone substitute |
| 04/21/2011 | US20110091538 Polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 04/21/2011 | US20110091532 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091468 Connective tissue growth factor antibodies |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091451 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 04/21/2011 | US20110091443 Heparin-conjugated fibrin gel and method and kit for preparing same |
| 04/21/2011 | US20110091434 Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucosyltransferase |
| 04/21/2011 | US20110091411 Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | DE202009017772U1 Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid Combination products with cytokine antagonist and corticosteroid |
| 04/21/2011 | CA2777629A1 Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof |
| 04/21/2011 | CA2777401A1 Stem cells for musculoskeletal tissue repair |
| 04/21/2011 | CA2776543A1 Inhibitors of bruton's tyrosine kinase |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311876A2 M-CSF-specific monoclonal antibody and uses thereof |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311529A1 Botanical extract composition |
| 04/20/2011 | EP2311482A1 Osteogenic synthetic BMP-7 peptides, pharmaceutical compositions cell culture medium containing same |
| 04/20/2011 | EP2311453A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2311440A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310024A2 Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| 04/20/2011 | EP2310005A2 Treatment of inflammatory conditions with isothiocyanates |
| 04/20/2011 | EP1449534B1 Ganoderma atrum extract as matrix metalloprotease inhibitor |
| 04/20/2011 | EP1082415B1 Methods useful for modulation of angiogenesis using tyrosine kinase src |
| 04/20/2011 | CN201798932U Formula bag for treating lumbar disc protrusion |
| 04/20/2011 | CN1935202B Monkshood extract and its preparing method |
| 04/20/2011 | CN1930190B Hyaluronic acid derivative and drug containing the same |
| 04/20/2011 | CN1730475B Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102018963A MiR-125a for adjusting regulated on activation normal T cell expressed and secreted (RANTES) expressions as well as composition and application thereof |
| 04/20/2011 | CN102018946A Medicament for treating scapulohumeral periarthritis |
| 04/20/2011 | CN102018925A Compound preparation for treating arthritis |